The cellular and molecular basis of co-artemether (artemether-lumefantrine) action

by Makanga, Michael Musakiriza
Published 2002

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

by Gbadoé Adama, Premji Zulfiqarali, Makanga Michael, Tiono Alfred B, Ogutu Bernhards, Ubben David, Marrast Anne, Gaye Oumar
Published 2010-01-01

Community screening and treatment of asymptomatic carriers of <it>Plasmodium falciparum </it>with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulati...

by Ubben David, Sagara Issaka, Gaye Oumar, Premji Zulfiqarali, Gbadoé Adama, Makanga Michael, Tiono Alfred B, Kern Steven E, Cousin Marc, Oladiran Fiyinfolu, Sander Oliver, Ogutu Bernhards
Published 2011-07-01

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership

by Ofori-Adjei David, Zijenah Lynn, Ndounga Mathieu, Ambene Herman PA, Kitua Andrew Y, Jaoko Walter G, Corrah Tumani, Ndumbe Peter M, Manyando Christine, Matee Mecky I, Agwale Simon, Shongwe Steven, Nyirenda Thomas, Makanga Michael
Published 2009-07-01